Cargando…
Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
Venous thromboembolism (VTE) is frequent among patients with cancer. Ambulatory cancer patients starting chemotherapy have a 5% to 10% risk of cancer associated thrombosis (CAT) within the first year after cancer diagnosis. This risk may vary according to patient characteristics, cancer location, ca...
Autores principales: | Rossel, Anne, Robert-Ebadi, Helia, Marti, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139813/ https://www.ncbi.nlm.nih.gov/pubmed/32155855 http://dx.doi.org/10.3390/cancers12030612 |
Ejemplares similares
-
Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020) -
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis
por: Rossel, Anne, et al.
Publicado: (2019) -
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients
por: Becattini, Cecilia, et al.
Publicado: (2020) -
D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis
por: Bellesini, Marta, et al.
Publicado: (2021) -
Risk Factors and Prediction Models for Venous Thromboembolism in Ambulatory Patients with Lung Cancer
por: Yan, Ann-Rong, et al.
Publicado: (2021)